Replies to post #109213 on Biotech Values

[DewDiligence]

…treatment with Denosumab or Zometa is as supportive care, not as cancer treatment like EXEL184 is testing.

This distinction is more semantic than scientific. All drugs used in the kinds of metastatic cancers we’re discussing are “supportive” insofar as the disease itself is terminal.